18 Sep TPS New Position Cassava Science – SAVA
Cassava Science- SAVA $30.40 1.5 Billion Market Cap Alzheimers Phase 3 play A much talked about and perhaps even maligned Biotech that is on the verge of potentially releasing mind blowing Phase 3 results for Alzheimers indication. Recently appointing a new CEO with a very strong pedigree and...